10x Genomics, Inc. Earnings Per Share, Basic and Diluted
10x Genomics, Inc. (TXG) reported Earnings Per Share, Basic and Diluted of -$5.37 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-26
- 10x Genomics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$3.87.
- 10x Genomics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.65.
- 10x Genomics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.41.
- 10x Genomics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.22.
- 10x Genomics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.37.
- 10x Genomics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.80.
- 10x Genomics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$8.40.
- 10x Genomics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$1.62.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$3.87 derived: net income ÷ weighted average shares · filed 2023-02-16 | -$4.61 derived: net income ÷ weighted average shares · filed 2023-02-16 | -$5.08 derived: net income ÷ weighted average shares · filed 2023-02-16 | -$5.37 10-K · filed 2021-02-26 |
| 2020-09-30 | -$0.65 10-Q · filed 2020-11-12 | -$1.06 derived: net income ÷ weighted average shares · filed 2021-11-05 | -$1.28 10-Q · filed 2020-11-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2021-11-05 |
| 2020-06-30 | -$0.41 10-Q · filed 2020-08-12 | -$0.63 10-Q · filed 2020-08-12 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-11-05 | -$0.97 derived: net income ÷ weighted average shares · filed 2021-11-05 |
| 2020-03-31 | -$0.22 10-Q · filed 2020-05-12 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-11-05 | -$0.51 derived: net income ÷ weighted average shares · filed 2021-11-05 | -$0.82 derived: net income ÷ weighted average shares · filed 2021-11-05 |
| 2019-12-31 | -$0.07 10-K · filed 2020-02-27 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.59 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$0.80 10-K · filed 2021-02-26 |
| 2019-09-30 | -$0.33 10-Q · filed 2020-11-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$1.21 10-Q · filed 2020-11-12 | -$5.42 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-06-30 | -$0.70 10-Q · filed 2020-08-12 | -$0.96 10-Q · filed 2020-08-12 | -$6.09 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$7.27 derived: net income ÷ weighted average shares · filed 2021-02-26 |
| 2019-03-31 | -$0.25 10-Q · filed 2020-05-12 | -$5.50 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$6.69 derived: net income ÷ weighted average shares · filed 2021-02-26 | |
| 2018-12-31 | -$5.40 10-K · filed 2020-02-27 | -$6.59 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$8.40 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$1.13 10-K · filed 2020-02-27 | -$2.80 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$0.45 10-K · filed 2020-02-27 | |||
| 2018-03-31 | -$1.23 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$1.62 10-K · filed 2020-02-27 |